Given that TP53 mutations in our selected cases were located over 4 exons in tumor tissue, our approach of sequencing all coding exons may have decreased the probability of detecting mutations due to unnecessary reduction of sequencing coverage. This evidence concerns the gene TP53 and neoplasm.